Cargando…

The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

BACKGROUND: Soluble urokinase-type plasminogen activator receptor (suPAR) is positively correlated with immune system activity. Inflammation can promote the development of chronic obstructive pulmonary disease (COPD). Therefore, this study conducted a systematic review and meta-analysis to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Qiangru, Xiong, Huaiyu, Shuai, Tiankui, Wang, Yalei, Zhang, Chuchu, Zhang, Meng, Zhu, Lei, Lu, Jiaju, Liu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350130/ https://www.ncbi.nlm.nih.gov/pubmed/32643535 http://dx.doi.org/10.1177/1753466620938546

Ejemplares similares

The Diagnostic and Prognostic Value of suPAR in Patients with Sepsis: A Systematic Review and Meta-Analysis
por: Huang, Qiangru, et al.
Publicado: (2020)

Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Huang, Qiangru, et al.
Publicado: (2020)

DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Huang, Qiangru, et al.
Publicado: (2020)

Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis
por: Shuai, Tiankui, et al.
Publicado: (2021)

Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis
por: Zhang, Chuchu, et al.
Publicado: (2021)

Assessment of comorbidities and prognosis in patients with COPD diagnosed with the fixed ratio and the lower limit of normal: a systematic review and meta-analysis
por: Xiong, Huaiyu, et al.
Publicado: (2020)

suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014)

suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)

suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022)

suPAR as a prognostic biomarker in sepsis
por: Donadello, Katia, et al.
Publicado: (2012)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

suPAR to Risk-Stratify Patients With Malaria
por: Stefanova, Veselina, et al.
Publicado: (2022)

Predictive value of suPAR in AKI: a systematic review and meta-analysis
por: Huang, Yan, et al.
Publicado: (2022)

suPAR, a Circulating Kidney Disease Factor
por: Wei, Changli, et al.
Publicado: (2021)

Prevalence of chronic obstructive pulmonary disease at high altitude: a systematic review and meta-analysis
por: Xiong, Huaiyu, et al.
Publicado: (2020)

The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis
por: Gustafsson, Anna, et al.
Publicado: (2012)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015)

Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery
por: Rasmussen, Sebastian Roed, et al.
Publicado: (2021)

Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis
por: Jiang, Binshan, et al.
Publicado: (2022)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
por: Rabensteiner, Jasmin, et al.
Publicado: (2016)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

suPAR Surprises as a Biomarker of Invasive Outcomes in Pleural Infection
por: Idell, Steven, et al.
Publicado: (2020)

The Perspective of Vitamin D on suPAR-Related AKI in COVID-19
por: Liao, Tzu-Hsien, et al.
Publicado: (2022)

The Association of suPAR with Cardiovascular Risk Factors in Young and Healthy Adults
por: Wohlwend, Niklas Fabio, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease and risk of lung cancer: a meta-analysis of prospective cohort studies
por: Zhang, Xinyue, et al.
Publicado: (2017)

Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Liu, Tao, et al.
Publicado: (2021)

The efficacy of N-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis
por: Huang, Chienhsiu, et al.
Publicado: (2023)

Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels
por: Gustafsson, Anna, et al.
Publicado: (2011)

SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis
por: Hodges, Gethin W, et al.
Publicado: (2018)

Plasma levels of the active form of suPAR are associated with COVID-19 severity
por: Huang, Mingxiang, et al.
Publicado: (2020)

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19
por: Altintas, Izzet, et al.
Publicado: (2021)

Assay-related differences in SuPAR levels: implications for measurement and data interpretation
por: Vasbinder, Alexi, et al.
Publicado: (2022)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

SuPAR mediates viral response proteinuria by rapidly changing podocyte function
por: Wei, Changli, et al.
Publicado: (2023)

Serum uric acid level as a biomarker for chronic obstructive pulmonary disease: a meta-analysis
por: Li, Herui, et al.
Publicado: (2021)

Elastography for the differential diagnosis of malignant versus benign testicular lesions: a meta-analysis
por: Lin, Ziwei, et al.
Publicado: (2021)

The Clinical Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Autoimmune Connective Tissue Disorders
por: Vasarhelyi, Barna, et al.
Publicado: (2016)

Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis
por: Vassiliou, Alice G., et al.
Publicado: (2022)

All-cause readmission rate and risk factors of 30- and 90-day after discharge in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Ruan, Huanrong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r9iq10lemqqa5dc2d68unnj92k